Rethinking Your Imaging Strategy

By Medidata

Most people involved in medical imaging are aware of the recent upheavals in the industry. Sponsors know that changes to their key Imaging relationships may be imminent. Anticipating these changes and properly handling them may well have an impact on your trial.

The current state of the clinical trial imaging industry can best be described as murky and unsettling and could put your timelines at risk. The wave of M&A activity across key imaging players has created confusion and a lack of transparency directly impacting sponsors and sites. The new mergers, acquisitions, and partnerships are causing disruptions across technology, process, and people.

This guide is designed to help you avoid the pitfalls in this disrupted landscape. Across eight parameters, learn how you can regain control of your Imaging strategy and leap ahead in the transformation of imaging for your trials.

Download to find out more.

Enter your details to receive the free white paper:

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.